(SPIB) Barclays Intermediate Term - Overview
Etf: Corporate Bonds, Intermediate Maturity
Dividends
| Dividend Yield | 4.81% |
| Yield on Cost 5y | 4.77% |
| Yield CAGR 5y | 27.16% |
| Payout Consistency | 93.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 1.90% |
| Relative Tail Risk | -2.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 2.74 |
| Character TTM | |
|---|---|
| Beta | 0.044 |
| Beta Downside | 0.015 |
| Drawdowns 3y | |
|---|---|
| Max DD | 3.51% |
| CAGR/Max DD | 1.76 |
Description: SPIB Barclays Intermediate Term January 03, 2026
The SPDR Barclays Intermediate Term Corporate Bond ETF (SPIB) commits at least 80% of its assets to securities that either belong to its benchmark index or have economic characteristics that are substantially identical to those index constituents. The underlying index tracks U.S. investment-grade corporate bonds with maturities from 1 to 10 years.
As of the most recent quarter, SPIB’s weighted-average maturity sits near 5.5 years, delivering a 30-day SEC yield of roughly 4.2% and a Bloomberg-reported duration of 4.8 years. Its expense ratio is 0.10%, positioning it among the lower-cost options in the intermediate-term corporate bond space.
Key drivers of SPIB’s performance include Federal Reserve policy (which directly influences intermediate-term rates), corporate credit spread dynamics (particularly in sectors like technology and industrials that dominate the index), and overall U.S. economic growth that affects issuers’ default risk. A widening spread or an unexpected rate hike could pressure the ETF’s price, while a stable or narrowing spread typically supports its yield.
For a more granular look at SPIB’s holdings, risk metrics, and scenario analysis, you might find a deeper dive on ValueRay useful.
What is the price of SPIB shares?
Over the past week, the price has changed by +0.24%, over one month by +0.36%, over three months by +1.33% and over the past year by +7.48%.
Is SPIB a buy, sell or hold?
What are the forecasts/targets for the SPIB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 37.1 | 9.5% |
SPIB Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 10.77b USD (10.77b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 10.77b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 10.77b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.08% (E(10.77b)/V(10.77b) * Re(6.08%) + (debt-free company))
Discount Rate = 6.08% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)